StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Tops Q4 EPS by 1c; Reports $5B Buyback; Guides FY11, Raises FY12 Outlook
February 1, 2011 8:03 AM
Pfizer Inc. (NYSE: PFE) reported Q4 EPS of $0.47, $0.01 better than the analyst estimate of $0.46 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Earnings
Guidance
Hot Earnings
Hot Guidance
Hot List
Stock Buybacks